Evidence map›Paper›PMID 24428701›Full record

ArticleAlcoholism, clinical and experimental research2014

Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats.

Nirelia M Idrus, Nancy N H McGough, Edward P Riley, Jennifer D Thomas

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Brain Structure and Function in Recovery.Alcohol research : current reviews · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Effects of developmental alcohol exposure vs. intubation stress on BDNF and TrkB expression in the hippocampus and frontal cortex of neonatal rats.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2015
    Article
  11. Fetal alcohol spectrum disorders and neuroimmune changes.International review of neurobiology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nirelia M IdrusCenter for Behavioral Teratology, Department of Psychology, San Diego State University, San Diego, California.
Nancy N H McGough
Edward P Riley
Jennifer D Thomas
San Diego State University · US

Funding

BEHAVIORAL EFFECTS OF NEONATAL ALCOHOL EXPOSURER01AA006902 · NIAAA · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI RILEY, EDWARD P · 1986 to 2010
$2.7M
NIAAA NIH HHS AA06902NIAAA NIH HHS R01 AA006902
6 · The paper itself

Abstract

backgroundPrenatal alcohol exposure can disrupt central nervous system development, manifesting as behavioral deficits that include motor, emotional, and cognitive dysfunction. Both clinical and animal studies have reported binge drinking during development to be highly correlated with an increased risk of fetal alcohol spectrum disorders (FASD). We hypothesized that binge drinking may be especially damaging because it is associated with episodes of alcohol withdrawal. Specifically, we have been investigating the possibility that NMDA receptor-mediated excitotoxicity occurs during alcohol withdrawal and contributes to developmental alcohol-related neuropathology. Consistent with this hypothesis, administration of the NMDA receptor antagonists MK-801 or eliprodil during withdrawal attenuates behavioral alterations associated with early alcohol exposure. In this study, we investigated the effects of memantine, a clinically used NMDA receptor antagonist, on minimizing ethanol-induced overactivity and spatial learning deficits.

methodsSprague-Dawley pups were exposed to 6.0 g/kg ethanol via intubation on postnatal day (PD) 6, a period of brain development that models late gestation in humans. Controls were intubated with a calorically matched maltose solution. During withdrawal, 24 and 36 hours after ethanol exposure, subjects were injected with a total of either 0, 20, or 30 mg/kg memantine. The subjects' locomotor levels were recorded in open field activity monitors on PDs 18 to 21 and on a serial spatial discrimination reversal learning task on PDs 40 to 43.

resultsAlcohol exposure induced overactivity and impaired performance in spatial learning. Memantine administration significantly attenuated the ethanol-associated behavioral alterations in a dose-dependent manner. Thus, memantine may be neuroprotective when administered during ethanol withdrawal.

conclusionsThese data have important implications for the treatment of EtOH's neurotoxic effects and provide further support that ethanol withdrawal significantly contributes to FASD.

Indexed as

Alcohol Withdrawal DeliriumAnimalsAnimals, NewbornBinge DrinkingCell CountCentral Nervous System DepressantsDiscrimination LearningEthanolExcitatory Amino Acid AntagonistsFemaleGrowthHyperkinesisLearning DisabilitiesMaleMaze LearningMemantineCentral Nervous System DepressantsEthanolExcitatory Amino Acid AntagonistsMemantineBinge EthanolExcitotoxicityFetal AlcoholNMDATreatment

Identifiers

PMID24428701
PMCPMC3946805
OpenAlexW2083108739

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.